Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Advanced Cervical Carcinoma
NCT00005999Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of arsenic trioxide in Cervical Cancer (CC), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Efficacy of arsenic trioxide. Started Apr 2000; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00005999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005999.